EDSA Edesa Biotech, Inc.
Edesa Biotech, Inc. (EDSA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: March 10, 2026 , by Nijhawan Pardeep .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Nijhawan Pardeep | Chief Executive Officer | Buy | 1,000 | $6.60 | $6.6K | 628,813 | |
| Nijhawan Pardeep | Chief Executive Officer | Buy | 10,000 | $3.90 | $39.0K | 402,702 | |
| Nijhawan Pardeep | Chief Executive Officer | Buy | 10,000 | $4.26 | $42.6K | 392,702 | |
| Nijhawan Pardeep | Chief Executive Officer | Buy | 10,000 | $3.63 | $36.3K | 382,702 | |
| Nijhawan Pardeep 2 fills | Chief Executive Officer | Buy | 3,000 | $2.09 | $6.3K | 627,813 | |
| Nijhawan Pardeep | Chief Executive Officer | Buy | 30,000 | $2.22 | $66.7K | 371,702 | |
| Nijhawan Pardeep | Chief Executive Officer | Buy | 20,571 | $1.58 | $32.5K | 615,797 | |
| Brooks Michael J | President | Buy | 2,000 | $1.57 | $3.1K | 226,870 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.